Alkaline phosphatase measurement
|
phenotype |
|
Laboratory Procedure
|
42
|
79
|
0.100 |
None |
1.000 |
5 |
7
|
2008 |
2019 |
Serum gamma-glutamyl transferase measurement
|
phenotype |
|
Laboratory Procedure
|
54
|
108
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Finding of liver enzyme levels
|
phenotype |
|
Laboratory or Test Result
|
7
|
10
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Measurement of liver enzyme
|
phenotype |
|
Laboratory Procedure
|
7
|
10
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
succinic semialdehyde dehydrogenase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Mental Disorders
|
Disease or Syndrome
|
7
|
17
|
0.100 |
None |
|
0 |
2
|
|
|
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.060 |
None |
1.000 |
6 |
|
2002 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2018 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2018 |
Multiple Chronic Conditions
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
929
|
42
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
trachomatis
|
disease |
|
Disease or Syndrome
|
175
|
7
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Vascular calcification
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
257
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Familial HDL deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Brain Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
114
|
11
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Budd-Chiari Syndrome
|
disease |
Digestive System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
24
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Leukemia, B-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
239
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |